-
1
-
-
0033050404
-
Increasing hematopoietic mixed chimerism alter BMT with total depletion of CD4+ and partial depletion of CD8+ lymphocytes is associated with a higher incidence of relapse
-
1:STN:280:DyaK1M7pvVKlsw%3D%3D 10100562 10.1038/sj.bmt.1701604
-
Serrano J, Roman J, Herrera C, Castillejo JA, Reina ML, Gonzalez MG, Rodriguez MC, Pascual A, Sanchez J, Torres A (1999) Increasing hematopoietic mixed chimerism alter BMT with total depletion of CD4+ and partial depletion of CD8+ lymphocytes is associated with a higher incidence of relapse. Bone Marrow Transplant 23:475-482
-
(1999)
Bone Marrow Transplant
, vol.23
, pp. 475-482
-
-
Serrano, J.1
Roman, J.2
Herrera, C.3
Castillejo, J.A.4
Reina, M.L.5
Gonzalez, M.G.6
Rodriguez, M.C.7
Pascual, A.8
Sanchez, J.9
Torres, A.10
-
2
-
-
0031933057
-
Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT
-
1:STN:280:DyaK1c7psVKltg%3D%3D 9535041 10.1038/sj.bmt.1701119
-
Bader P, Beck J, Frey A, Schlegel PG, Hebarth H, Handgretinger R, Einsele H, Niemeyer C, Benda N, Faul C, Kanz L, Niethammer D, Klingebiel T (1998) Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT. Bone Marrow Transplant 21:487-495
-
(1998)
Bone Marrow Transplant
, vol.21
, pp. 487-495
-
-
Bader, P.1
Beck, J.2
Frey, A.3
Schlegel, P.G.4
Hebarth, H.5
Handgretinger, R.6
Einsele, H.7
Niemeyer, C.8
Benda, N.9
Faul, C.10
Kanz, L.11
Niethammer, D.12
Klingebiel, T.13
-
3
-
-
85009893939
-
Long-term follow up of persisting mixed chimerism after partially T cell depleted allogeneic stem cell transplantation
-
1:STN:280:DC%2BD387gvVKmsQ%3D%3D 11840258 10.1038/sj.leu.2402343
-
Schaap N, Schattenberg A, Mensink E, Prejiers F, Hillegers M, Knops R, Pennings A, Boezeman J, Geurts van Kessel A, de Pauw B, de Witte T (2002) Long-term follow up of persisting mixed chimerism after partially T cell depleted allogeneic stem cell transplantation. Leukemia 16:13-21
-
(2002)
Leukemia
, vol.16
, pp. 13-21
-
-
Schaap, N.1
Schattenberg, A.2
Mensink, E.3
Prejiers, F.4
Hillegers, M.5
Knops, R.6
Pennings, A.7
Boezeman, J.8
Geurts Van Kessel, A.9
De Pauw, B.10
De Witte, T.11
-
4
-
-
0141475940
-
Impact or prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation
-
12766882 10.1016/S1083-8791(03)00077-6
-
Dey BR, McAfee S, Colby C, Sackestein R, Saidman S, Tarbell N, Sachs DH, Sykes M, Spitzer TR (2003) Impact or prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation. Biol Blood Marrow Transplant 9(5):320-329
-
(2003)
Biol Blood Marrow Transplant
, vol.9
, Issue.5
, pp. 320-329
-
-
Dey, B.R.1
McAfee, S.2
Colby, C.3
Sackestein, R.4
Saidman, S.5
Tarbell, N.6
Sachs, D.H.7
Sykes, M.8
Spitzer, T.R.9
-
5
-
-
18644365146
-
Evaluation of immunomodulatory treatment based on conventional and lineage-specific chimerism analysis in patients with myeloid malignancies after myeloablative allogeneic hematopoietic cell transplantation
-
1:CAS:528:DC%2BD2MXjsFOktbc%3D 15772700 10.1038/sj.leu.2403719
-
Zeiser R, Spyridonidis A, Wäsch R, Ihorst G, Grüllich C, Bertz H, Finke J (2005) Evaluation of immunomodulatory treatment based on conventional and lineage-specific chimerism analysis in patients with myeloid malignancies after myeloablative allogeneic hematopoietic cell transplantation. Leukemia 19:814-821
-
(2005)
Leukemia
, vol.19
, pp. 814-821
-
-
Zeiser, R.1
Spyridonidis, A.2
Wäsch, R.3
Ihorst, G.4
Grüllich, C.5
Bertz, H.6
Finke, J.7
-
6
-
-
84881370213
-
CD34(+) lineage specific donor cell chimerism for the diagnosis and treatment of impending relapse of AML or myelodysplastic syndrome after allo-SCT
-
Feb 4. doi: 10.1038/bmt.2013.2. [Epub ahead of print]
-
Rosenow F, Berkenmeier A, Krug U, Müller-Tidow C, Gerss J, Silling G, Groth C, Wieacker P, Bogdanova N, Mesters R, Büchner T, Kienast J, Berdel WE, Stelljes M. (2013) CD34(+) lineage specific donor cell chimerism for the diagnosis and treatment of impending relapse of AML or myelodysplastic syndrome after allo-SCT. Bone Marrow Transplant. 2013 Feb 4. doi: 10.1038/bmt.2013.2. [Epub ahead of print]
-
(2013)
Bone Marrow Transplant
-
-
Rosenow F, B.1
-
7
-
-
0031594385
-
Detection of CBFbeta/MYH11 fusion transcripts in patients with inv (16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation
-
10.1038/sj.bmt.1701056
-
Elmaaglacli AH, Beelen DW, Kroll M, Trzenky S, Stein C, Schaefer UW (1998) Detection of CBFbeta/MYH11 fusion transcripts in patients with inv (16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation. Bone Marrow Transplant 2:159-166
-
(1998)
Bone Marrow Transplant
, vol.2
, pp. 159-166
-
-
Elmaaglacli, A.H.1
Beelen, D.W.2
Kroll, M.3
Trzenky, S.4
Stein, C.5
Schaefer, U.W.6
-
8
-
-
0642368568
-
Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias
-
1:CAS:528:DC%2BD2cXpsVajsrg%3D 14645432 10.1200/JCO.2003.03.166
-
Krauter J, Gorlich K, Ottmann O, Lubbert M, Dohner H, Heit W, Kanz L, Ganser A, Heil G (2003) Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias. J Clin Oncol 21(23):4413-4422
-
(2003)
J Clin Oncol
, vol.21
, Issue.23
, pp. 4413-4422
-
-
Krauter, J.1
Gorlich, K.2
Ottmann, O.3
Lubbert, M.4
Dohner, H.5
Heit, W.6
Kanz, L.7
Ganser, A.8
Heil, G.9
-
9
-
-
47649090155
-
Reduced-toxicity conditioning with fludarabine, BCNU and melphalan in allogeneic hematopoietic cell transplantation: Particular activity against advanced hematologic malignancies
-
1:CAS:528:DC%2BD1cXos1Cit7c%3D 18451310 10.1182/blood-2007-08-104745
-
Marks R, Potthoff K, Hahn J, Ihorst G, Bertz H, Spyridonidis A, Holler E, Finke J (2008) Reduced-toxicity conditioning with fludarabine, BCNU and melphalan in allogeneic hematopoietic cell transplantation: particular activity against advanced hematologic malignancies. Blood 112(2):415-425
-
(2008)
Blood
, vol.112
, Issue.2
, pp. 415-425
-
-
Marks, R.1
Potthoff, K.2
Hahn, J.3
Ihorst, G.4
Bertz, H.5
Spyridonidis, A.6
Holler, E.7
Finke, J.8
-
10
-
-
84875417640
-
An internal validation approach and quality control on hematopoietic chimerism testing after allogeneic hematopoietic cell transplantation
-
1:CAS:528:DC%2BC3sXkslSmsr8%3D 23093278 10.1515/cclm-2012-0230
-
Waterhouse M, Kunzmann R, Torres M, Bertz H, Finke J (2013) An internal validation approach and quality control on hematopoietic chimerism testing after allogeneic hematopoietic cell transplantation. Clin Chem Lab Med 51(2):363-369
-
(2013)
Clin Chem Lab Med
, vol.51
, Issue.2
, pp. 363-369
-
-
Waterhouse, M.1
Kunzmann, R.2
Torres, M.3
Bertz, H.4
Finke, J.5
-
11
-
-
19044393661
-
Capillary electrophoresis for chimerism monitoring by PCR amplification of microsatellite markers after allogeneic hematopoietic cell transplantation
-
15877797 10.1111/j.1399-0012.2005.00347.x
-
Spyridonidis A, Zeiser R, Wäsch R, Bertz H, Finke J (2005) Capillary electrophoresis for chimerism monitoring by PCR amplification of microsatellite markers after allogeneic hematopoietic cell transplantation. Clin Transplant 19:350-356
-
(2005)
Clin Transplant
, vol.19
, pp. 350-356
-
-
Spyridonidis, A.1
Zeiser, R.2
Wäsch, R.3
Bertz, H.4
Finke, J.5
-
12
-
-
46949098927
-
A rapid one step assay for simultaneous detection of FLT3/ITD and NPM1 mutations in AML with normal cytogenetics
-
1:CAS:528:DC%2BD1cXhtVWqu7vO 18477048 10.1111/j.1365-2141.2008.07205.x
-
Huang Q, Chen W, Gaal K et al (2008) A rapid one step assay for simultaneous detection of FLT3/ITD and NPM1 mutations in AML with normal cytogenetics. Br J Haematol 142:489-501
-
(2008)
Br J Haematol
, vol.142
, pp. 489-501
-
-
Huang, Q.1
Chen, W.2
Gaal, K.3
-
13
-
-
17744376761
-
Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers
-
1:CAS:528:DC%2BD3MXhvFelsb4%3D 11236950 10.1038/sj.leu.2401953
-
Thiede C, Bornhäuser M, Oelschlägel U, Brendel C, Leo R, Daxberger H, Mohr B, Florek M, Kroschinsky F, Geissler G, Naumann R, Ritter M, Prange-Krex G, Lion T, Neubauer A, Ehninger G (2001) Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers. Leukemia 15:293-302
-
(2001)
Leukemia
, vol.15
, pp. 293-302
-
-
Thiede, C.1
Bornhäuser, M.2
Oelschlägel, U.3
Brendel, C.4
Leo, R.5
Daxberger, H.6
Mohr, B.7
Florek, M.8
Kroschinsky, F.9
Geissler, G.10
Naumann, R.11
Ritter, M.12
Prange-Krex, G.13
Lion, T.14
Neubauer, A.15
Ehninger, G.16
-
14
-
-
0024580745
-
Mixed hematopoietic chimerism after allogeneic transplantation with lymphocyte-depleted bone marrow is not associated with a higher incidence of relapse
-
1:STN:280:DyaL1M7psVerug%3D%3D 2564791
-
Schattenberg A, De Witte T, Salden M, Vet J, Van Dijk B, Smeets D, Hoogenhout J, Haanen C (1989) Mixed hematopoietic chimerism after allogeneic transplantation with lymphocyte-depleted bone marrow is not associated with a higher incidence of relapse. Blood 73(5):1367-1372
-
(1989)
Blood
, vol.73
, Issue.5
, pp. 1367-1372
-
-
Schattenberg, A.1
De Witte, T.2
Salden, M.3
Vet, J.4
Van Dijk, B.5
Smeets, D.6
Hoogenhout, J.7
Haanen, C.8
-
15
-
-
0027227876
-
Mixed T lymphoid chimerism after allogeneic bone marrow transplantation for hematologic malignancies of children is not correlated with relapse
-
8400242
-
van Leeuwen JE, van Tol MJ, Joosten AM, Wijnen JT, Khan PM, Vossen JM (1993) Mixed T lymphoid chimerism after allogeneic bone marrow transplantation for hematologic malignancies of children is not correlated with relapse. Blood 82(6):1921-1928
-
(1993)
Blood
, vol.82
, Issue.6
, pp. 1921-1928
-
-
Van Leeuwen, J.E.1
Van Tol, M.J.2
Joosten, A.M.3
Wijnen, J.T.4
Khan, P.M.5
Vossen, J.M.6
-
16
-
-
0028905531
-
Detection of minimal residual disease in acute leukemia: Methodologic advances and clinical significance
-
1:CAS:528:DyaK2MXktlOgtLw%3D 7888664
-
Campana D, Pui CH (1995) Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood 85(6):1416-1434
-
(1995)
Blood
, vol.85
, Issue.6
, pp. 1416-1434
-
-
Campana, D.1
Pui, C.H.2
-
17
-
-
0038268132
-
Determination of minimal residual disease in leukemia patients
-
12786792 10.1046/j.1365-2141.2003.04393.x
-
Campana D (2003) Determination of minimal residual disease in leukemia patients. Br J Haematol 121(6):823-838
-
(2003)
Br J Haematol
, vol.121
, Issue.6
, pp. 823-838
-
-
Campana, D.1
-
18
-
-
0036659931
-
Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: Correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease
-
1:CAS:528:DC%2BD38XltF2rs7g%3D 12070009 10.1182/blood.V100.1.59
-
Schnittger S, Schoch C, Dugas M, Kern W, Staib P, Wuchter C, Löffler H, Sauerland CM, Serve H, Büchner T, Haferlach T, Hiddemann W (2002) Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. Blood 100(1):59-66
-
(2002)
Blood
, vol.100
, Issue.1
, pp. 59-66
-
-
Schnittger, S.1
Schoch, C.2
Dugas, M.3
Kern, W.4
Staib, P.5
Wuchter, C.6
Löffler, H.7
Sauerland, C.M.8
Serve, H.9
Büchner, T.10
Haferlach, T.11
Hiddemann, W.12
-
19
-
-
70349579540
-
Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AML
-
1:CAS:528:DC%2BD1MXhtFOgtrbF 19587375 10.1182/blood-2009-03-213389
-
Schnittger S, Kern W, Tschulik C, Weiss T, Dicker F, Falini B, Haferlach C, Haferlach T (2009) Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AML. Blood 114(11):2220-2231
-
(2009)
Blood
, vol.114
, Issue.11
, pp. 2220-2231
-
-
Schnittger, S.1
Kern, W.2
Tschulik, C.3
Weiss, T.4
Dicker, F.5
Falini, B.6
Haferlach, C.7
Haferlach, T.8
-
20
-
-
33745198953
-
Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples
-
1:CAS:528:DC%2BD28XlvFGjur8%3D 16642044 10.1038/sj.leu.2404246
-
Cloos J, Goemans BF, Hess CJ, van Oostveen JW, Waisfisz Q, Corthals S, de Lange D, Boeckx N, Hählen K, Reinhardt D, Creutzig U, Schuurhuis GJ, Zwaan CM, Kaspers GJ (2006) Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples. Leukemia 20(7):1217-1220
-
(2006)
Leukemia
, vol.20
, Issue.7
, pp. 1217-1220
-
-
Cloos, J.1
Goemans, B.F.2
Hess, C.J.3
Van Oostveen, J.W.4
Waisfisz, Q.5
Corthals, S.6
De Lange, D.7
Boeckx, N.8
Hählen, K.9
Reinhardt, D.10
Creutzig, U.11
Schuurhuis, G.J.12
Zwaan, C.M.13
Kaspers, G.J.14
-
21
-
-
58649090874
-
Monitoring minimal residual disease in acute myeloid leukemia with NPM1 mutations by quantitative PCR: Clonal evolution is a limiting factor
-
1:CAS:528:DC%2BD1MXjtlehtrw%3D 19055671 10.1111/j.1365-2141.2008.07488.x
-
Papadaki C, Dufuor A, Seibl M, Schneider S, Bohlander SK, Zellmeier E, Mellert G, Hiddemann W, Spiekermann K (2009) Monitoring minimal residual disease in acute myeloid leukemia with NPM1 mutations by quantitative PCR: clonal evolution is a limiting factor. Br J Haematol 144(4):517-523
-
(2009)
Br J Haematol
, vol.144
, Issue.4
, pp. 517-523
-
-
Papadaki, C.1
Dufuor, A.2
Seibl, M.3
Schneider, S.4
Bohlander, S.K.5
Zellmeier, E.6
Mellert, G.7
Hiddemann, W.8
Spiekermann, K.9
-
22
-
-
84875638262
-
Influence of molecular subgroups on outcome of acute myeloid leukemia with normal karyotype in 141 patients undergoing salvage allogeneic stem cell transplantation in primary induction failure or beyond first relapse
-
22983588 10.3324/haematol.2012.070235
-
Pfeiffer T, Schleuning M, Mayer J, Haude KH, Tischer J, Buchholz S, Bunjes D, Bug G, Holler E, Meyer RG, Greinix H, Scheid C, Christopeit M, Schnittger S, Braess J, Schlimok G, Spiekermann K, Ganser A, Kolb HJ, Schmid C (2013) Influence of molecular subgroups on outcome of acute myeloid leukemia with normal karyotype in 141 patients undergoing salvage allogeneic stem cell transplantation in primary induction failure or beyond first relapse. Haematologica 98(4):518-525
-
(2013)
Haematologica
, vol.98
, Issue.4
, pp. 518-525
-
-
Pfeiffer, T.1
Schleuning, M.2
Mayer, J.3
Haude, K.H.4
Tischer, J.5
Buchholz, S.6
Bunjes, D.7
Bug, G.8
Holler, E.9
Meyer, R.G.10
Greinix, H.11
Scheid, C.12
Christopeit, M.13
Schnittger, S.14
Braess, J.15
Schlimok, G.16
Spiekermann, K.17
Ganser, A.18
Kolb, H.J.19
Schmid, C.20
more..
|